The U.S. Centers for Disease Control's vaccine advisory committee voted to recommend the single-dose vaccine, Vimkunya, for the prevention chikungunya in 12 years and older traveling to a country ...

Recommendation of first chikungunya vaccine for persons as young as 12 years old expands access for US travelers to regions with outbreak or ...

Denmark's Bavarian Nordic said on Monday the U.S. Food and Drug Administration has approved a freeze-dried formulation of its mpox and smallpox vaccine.

For meningococcal vaccines, ACIP recommended that GSK's pentavalent vaccine (Penmenvy), designed to protect against A, B, C, ...

Discover why BVNKF's vaccine innovations, growth catalysts, and compelling valuation after a 52% pullback make it a strong ...

This recent safety and effectiveness data regarding mpox vaccination with Jynneos is important and timely given the ongoing global outbreak.

Vimkunya is now available in the US for the prevention of disease caused by chikungunya virus in individuals 12 years of age ...

In a statement on Thursday, April 10, the Health Cabinet Secretary, Aden Duale, confirmed that the country has received ...

The formulation allows for greater stockpiling, with Bavarian Nordic already working with the US government to add to vaccine reserves.

The US Food and Drug Administration (FDA) has approved the freeze-dried formulation of Bavarian Nordic’s smallpox and mpox vaccine in a move expected to provide flexibility in stockpiling the jab.